K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

1
Player Avatar siri22 (< 20) Submitted: 11/9/2011 1:53:03 AM : Outperform Start Price: $1.65 KV-A Score: -25.77

Lttle chinese mix>

Report this Post Reply

Featured Broker Partners


Advertisement